Work

Abstract PD5-6: Sustained hyperactivated mTOR & JAK2/STAT3 pathways in inflammatory breast cancer (IBC): Evidence for mTOR plus JAK2 therapeutic targeting

Year: 2013

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs13-pd5-6

Authors: K Jhaveri, E Teplinsky, R Arzu, S Giashuddin, Y Sarfraz, M Alexander, F Darvishian, D Silvera, PH Levine, S Hashmi, HJ Hoffman, L Paul, B Singh, JD Goldberg, T Hochman, S Formenti, A Valeta, MS Moran, RJ Schneider

Institutions: Brooklyn Hospital Center, George Washington University, Yale University, New York University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2037480462

Cites:

Cited by:

Related to: 10